Exchange: NASDAQ·Updated 03:09 PM EDT
CRBU logo

CRBU Caribou Biosciences Inc

$1.54
$0.085
(5.25%)
Today
Reported EarningsAug 13
Mkt Cap$173.68M
Vol744,049.00

About CRBU

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
81

Extremely Bullish Sentiment

How do you feel about CRBU?

Advertisement|Remove ads.